Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Paolicchi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Pharmacogenomics|May 7, 2014
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patientsMina Maftouh, Amir Avan, Niccola Funel, et al.
Occupational and Environmental Medicine|March 27, 2017
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individualsChiara De Santi, Perla Pucci, Alessandra Bonotti, et al.
Scientific Reports|March 11, 2015
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative riskGisella Figlioli, Bowang Chen, Rossella Elisei, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2014
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer riskGisella Figlioli, Aleksandra Köhler, Bowang Chen, et al.
International Journal of Cancer|June 19, 2019
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibilityBarbara Pardini, Alda Corrado, Elisa Paolicchi, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Pharmacogenomics|May 7, 2014
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patientsMina Maftouh, Amir Avan, Niccola Funel, et al.
Occupational and Environmental Medicine|March 27, 2017
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individualsChiara De Santi, Perla Pucci, Alessandra Bonotti, et al.
Scientific Reports|March 11, 2015
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative riskGisella Figlioli, Bowang Chen, Rossella Elisei, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2014
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer riskGisella Figlioli, Aleksandra Köhler, Bowang Chen, et al.
International Journal of Cancer|June 19, 2019
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibilityBarbara Pardini, Alda Corrado, Elisa Paolicchi, et al.
Pageof 2